Evidence map›Paper›PMID 32724032›Full record

ArticleRevista espanola de salud publica2020

[Can a tuberculosis research program promoted by a scientific society contribute to the control of the disease?]

Teresa Rodrigo Sanz, Joan A Caylà, José Mª García-García

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Revista espanola de salud publica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Teresa Rodrigo SanzGestora de Proyectos del Programa Integrado de Investigación en Tuberculosis (PII-TB) de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Barcelona. España.
Joan A CaylàDirector del PII-TB de la SEPAR (2006-2016). Barcelona. España.
José Mª García-GarcíaDirector del PII-TB de la SEPAR (2016-actualidad). Barcelona. España.
Sociedad Española de Neumología y Cirugía Torácica · ESFC Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although Spain is a developed country, Tuberculosis (TB) was for years a disease with high incidence rates compared to other European countries, a situation that worsened with the HIV/AIDS epidemic and with the increase of immigration. The Spanish Respiratory Society (SEPAR) created in 2004 the Integrated Research Programs (PII) on respiratory diseases, including TB (PII-TB) which has carried out studies related to the five lines of research that it maintains: clinical / epidemiological, microbiological, technological/clinical management, evaluative, and international cooperation. Following the recommendations on the necessity to evaluate health programs made by international organizations, the evaluation of PII-TB was recently carried out, revealing the situation of the main variables of the disease and their evolution over the time that the program has been working. PII-TB has generated abundant data on the situation of this disease in our country in years when this information has been limited. The fact that the results of the studies have been widely disseminated makes it easier for all professionals involved in the prevention, diagnosis and treatment of TB to implement and/or to improve activities that, finally, will contribute to the control of this disease.

Indexed as

Societies, ScientificAntitubercular AgentsBiomedical ResearchEmigration and ImmigrationEuropeHumansInternational CooperationProgram EvaluationPublicationsSpainTuberculosisAntitubercular AgentsEvaluationInvestigationProgramSpainTuberculosis

Identifiers

PMID32724032
PMCPMC11582860
OpenAlexW3046811956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.